Key facts
- This page summarizes Kate McKinley's Form 4 filing for Rani Therapeutics Holdings, Inc. (RANI).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 16 Dec 2024, 18:00.
Kate McKinley - 13 Dec 2024 Form 4 Insider Report for Rani Therapeutics Holdings, Inc. (RANI)
- Reporting relationship
- Chief Business Officer
- Issuer ticker
- RANI
- Reported as of
- 13 Dec 2024
- Net transaction value
- +$29,993
- SEC form
- 4
- Accepted by SEC
- 16 Dec 2024, 18:00:49 UTC
- Prior SEC filing
- 22 Mar 2024
- Next SEC filing
- 23 May 2025
- Source filing
- View source filing
- Reporting owner signature
- Kate McKinley
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Kate McKinley filed Form 4 for Rani Therapeutics Holdings, Inc. (RANI) on 16 Dec 2024.
Change
- Previous filing in this sequence was filed on 22 Mar 2024.
- Current net transaction value: +$29,993.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RANI
transaction
Class A Common Stock
Purchase
- Transaction value
- $29,993
- Shares
- +17,960
- Change %
- Price
- $1.67
- Shares after
- 17,960
- Date
- 13 Dec 2024
- Ownership
- Direct
* marks a reported price that did not pass the local price check.